(1)
Pappagallo, G.; Rizzo, M. Directness and Quality of Evidence of Bevacizumab Combined With Chemotherapy for Platinum-Resistant, Recurrent Ovarian Cancer in the AURELIA Trial:  . CBN 2014, 2, 39-41.